Sacral Nerve Stimulation Market is Anticipated to Witness High Growth Owing to Rising Geriatric Population
Global Sacral Nerve Stimulation Market |
Global
sacral nerve stimulation is a minimally invasive treatment method that involves
the use of an implantable medical device to deliver mild electrical pulses to
sacral nerves in order to manage bladder, bowel and sexual dysfunction. Sacral
nerve stimulation devices include tined leads, implantable pulse generators and
external trial stimulators. These devices help modulate neural pathways in the
sacral nerve and ultimately treat voiding dysfunction, fecal incontinence and
pelvic pain. The growing geriatric population suffering from neurological and
urological disorders has been a major factor driving the adoption of sacral
nerve stimulation therapy.
The
global sacral nerve stimulation market is estimated to be valued at US$ 422.7 Mn in 2024 and is expected to
exhibit a CAGR of 6.0% over the
forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Global
Sacral Nerve Stimulation Market Demand are Medtronic plc., Boston
Scientific Corporation, Nevro Corp, StimWave Technologies Inc., Axonics, Inc.,
Synapse Biomedical, Uroplasty, St. Jude Medical, Cogentix Medical. Sacral nerve
stimulation offers minimally invasive treatment options for patients who fail
to respond to conventional therapies such as biofeedback, pelvic floor
exercises or medication. The aging population worldwide and growing healthcare
expenditure in emerging economies create significant opportunities for players
in this market. Major companies are focusing on new product innovations,
geographic expansion and acquisitions to strengthen their market position.
Market Drivers
Rising Geriatric Population: The elderly population is more prone to experience
urinary incontinence, bowel dysfunction and pelvic floor disorders due to
weakening muscles and nerves over time. According to the United Nations, the
number of people aged 60 years and older is expected to more than double by
2050. This growing geriatric demographic will augment the demand for sacral
nerve stimulation therapy.
Market Restrains
High Cost of Devices: Sacral nerve stimulation devices involve significant
capital expenditure for implantable pulse generators, leads and surgical
procedures. While effective in managing voiding dysfunctions, the high upfront
costs pose affordability challenges. This can negatively impact market growth,
especially in price-sensitive developing countries.
Segment Analysis
The global sacral nerve stimulation market is segmented on the basis of
implantable & non-implantable devices and application. Implantable devices
sub segment dominates the market owing to its advantages over non-implantable
devices. Implantable devices offer continuous stimulation over long term period
which provides effective treatment for urinary & fecal incontinence.
Under application segmentation, the urinary incontinence indication holds the
highest market share. Urinary incontinence is the most common type of
incontinence and needs immediate medical help. It has significant impact on
quality of life. Thus, sacral nerve stimulation provides effective therapy for
treating urinary incontinence and remains the dominating sub segment.
Global Analysis
North America accounts for the largest share in the global sacral nerve
stimulation market due to robust reimbursement structure and high healthcare
spending. Presence of major players and adoption of innovative technologies
further supports market growth. Europe stands as the second largest market for
sacral nerve stimulationdevices. Asia Pacific shows highest growth rate owing
to rising healthcare expenditures, increasing patient awareness and improving
accessibility to advanced medical services. Growing geriatric population
vulnerable to incontinence drives the regional market growth over the forecast
period.
Get more insights on Global
Sacral Nerve Stimulation Market
Comments
Post a Comment